The main difference: retatrutide adds glucagon receptor activation for increased energy expenditure, potentially leading to greater fat loss than tirzepatides dual-action approach
This is not a "nice to have." It is a pharmacologically relevant factor that directly impacts how well your medication works
Discontinue Saxenda if the patient has not had a reduction in BMI of at least 1% from baseline
Blue Cross Blue Shield of Massachusetts and Point32Health are discontinuing coverage of GLP-1 medications for weight loss, and CVS Caremark has restricted its formulary to Wegovy, removing Zepbound
Dietary changes Drink fluids Staying well hydrated is essential if you have diarrhoea
Nocturia disrupting sleep : Waking multiple times nightly to urinate may indicate uncontrolled diabetes, heart failure, sleep apnea, or prostate issues in men